INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

GABELLI FUNDS LLC's Holding History (CIK: 0001081407)

Note: Option positions (PUT/CALL) are excluded.

Q2 2019
Shares 2,666,000 Value ($000) $2,376 Avg Close — Range —
Q1 2019
Shares 2,666,000 Value ($000) $2,645 Avg Close — Range —
Q4 2018
Shares 2,666,000 Value ($000) $2,465 Avg Close — Range —
Q3 2018
Shares 3,166,000 Value ($000) $3,194 Avg Close — Range —
Q2 2018
Shares 3,166,000 Value ($000) $2,784 Avg Close — Range —
Q1 2018
Shares 3,166,000 Value ($000) $2,556 Avg Close — Range —
Q4 2017
Shares 3,166,000 Value ($000) $2,554 Avg Close — Range —
Q3 2017
Shares 4,000,000 Value ($000) $3,090 Avg Close — Range —
Q2 2017
Shares 4,000,000 Value ($000) $3,890 Avg Close — Range —
Q1 2017
Shares 4,000,000 Value ($000) $3,728 Avg Close — Range —
Q4 2016
Shares 2,167,000 Value ($000) $1,931 Avg Close — Range —
Q3 2016
Shares 1,500,000 Value ($000) $1,677 Avg Close — Range —